Strides sells arm’s manufacturing unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday said it has entered into a binding agreement to sell biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma (SBL) to Syngene International ...
